DEA continues to make empty promises on clinical cannabis research
Surprised? You shouldn’t be. The DEA possesses an abysmal track record when it comes to enabling scientists to engage in cannabis-specific studies in the United States, in particular research evaluating the plant’s therapeutic efficacy. With such a checkered past, it is easy to see why many remain incredulous that the DEA’s latest actions are in…
Recent Comments